{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:55:14Z","timestamp":1788998114000,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871940"],"award-info":[{"award-number":["81871940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802751"],"award-info":[{"award-number":["81802751"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Science Fund for Distinguished Young Scholars","award":["81625016"],"award-info":[{"award-number":["81625016"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.canlet.2019.01.013","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T11:59:09Z","timestamp":1547812749000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK\/ERK pathway in pancreatic cancer"],"prefix":"10.1016","volume":"446","author":[{"given":"He","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guopei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhou","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-7143","authenticated-orcid":false,"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2019.01.013_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"Ca - Cancer J. Clin. 2017"},{"issue":"7540","key":"10.1016\/j.canlet.2019.01.013_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2019.01.013_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/bjc.2014.215","article-title":"Oncogenic KRAS signalling in pancreatic cancer","volume":"111","author":"Eser","year":"2014","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2019.01.013_bib4","article-title":"Stromal biology and therapy in pancreatic cancer: ready for clinical translation?","author":"Neesse","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.canlet.2019.01.013_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canlet.2016.02.057","article-title":"Prevailing over T cell exhaustion: new developments in the immunotherapy of pancreatic cancer","volume":"381","author":"Bauer","year":"2016","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.canlet.2019.01.013_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/icb.2013.12","article-title":"Modulating T regulatory cells in cancer: how close are we?","volume":"91","author":"Banerjee","year":"2013","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.canlet.2019.01.013_bib7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.pan.2016.09.007","article-title":"The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients","volume":"16","author":"Cheng","year":"2016","journal-title":"Pancreatology : Official J. Int. Assoc. Pancreatol."},{"key":"10.1016\/j.canlet.2019.01.013_bib8","first-page":"8227e35","article-title":"High intratumoral FOXP3(t) T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer","volume":"8","author":"Hanke","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2019.01.013_bib9","article-title":"An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma","volume":"9","author":"Tang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.canlet.2019.01.013_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/cimm.1997.1224","article-title":"Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations","volume":"182","author":"Abrams","year":"1997","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2019.01.013_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/2326-6066.CIR-15-0241","article-title":"Mutant KRAS conversion of conventional T cells into regulatory T cells","volume":"4","author":"Zdanov","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.canlet.2019.01.013_bib12","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/ijc.30650","article-title":"Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients","volume":"140","author":"Cheng","year":"2017","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2019.01.013_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2018.01.017","article-title":"MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer","volume":"418","author":"Fan","year":"2018","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.canlet.2019.01.013_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc2899","article-title":"KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma","volume":"10","author":"Morris","year":"2010","journal-title":"Nat. Rev. Canc."},{"issue":"2","key":"10.1016\/j.canlet.2019.01.013_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI59227","article-title":"Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice","volume":"122","author":"Collins","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.canlet.2019.01.013_bib16","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/cncr.29364","article-title":"Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer","volume":"121","author":"Kinugasa","year":"2015","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2019.01.013_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00535-012-0664-2","article-title":"Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer","volume":"48","author":"Ogura","year":"2013","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.canlet.2019.01.013_bib18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<450::AID-IJC10>3.0.CO;2-E","article-title":"Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I\/II study","volume":"65","author":"Gjertsen","year":"1996","journal-title":"Int. J. Canc."},{"issue":"8987","key":"10.1016\/j.canlet.2019.01.013_bib19","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(95)92408-6","article-title":"Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation","volume":"346","author":"Gjertsen","year":"1995","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.canlet.2019.01.013_bib20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.10187","article-title":"Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma","volume":"103","author":"Wang","year":"2016","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.canlet.2019.01.013_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/1078-0432.CCR-17-1090","article-title":"KRAS mutation and consensus molecular subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer","volume":"24","author":"Lal","year":"2018","journal-title":"Clin. Canc. Res. : Official J. Am. Assoc. Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2019.01.013_bib22","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00262-017-2005-z","article-title":"KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma","volume":"66","author":"Chen","year":"2017","journal-title":"Cancer Immunol. Immunother. CII"},{"issue":"1","key":"10.1016\/j.canlet.2019.01.013_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10010006","article-title":"Immune evasion in pancreatic cancer: from mechanisms to therapy","volume":"10","author":"Martinez-Bosch","year":"2018","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.canlet.2019.01.013_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.canlet.2019.01.013_bib25","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/0008-5472.CAN-11-3850","article-title":"Therapeutic efficacy of bifunctional siRNA combining TGF-beta1 silencing with RIG-I activation in pancreatic cancer","volume":"73","author":"Ellermeier","year":"2013","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2019.01.013_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/cgt.2016.66","article-title":"T-cell programming in pancreatic adenocarcinoma: a review","volume":"24","author":"Seo","year":"2017","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.canlet.2019.01.013_bib27","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/eji.201041073","article-title":"Integrated T-cell receptor and costimulatory signals determine TGF-beta-dependent differentiation and maintenance of Foxp3+ regulatory T cells","volume":"41","author":"Gabrysova","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2019.01.013_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/imm.12397","article-title":"MEK inhibition prevents tumour-shed transforming growth factor-beta-induced T-regulatory cell augmentation in tumour milieu","volume":"144","author":"Hossain","year":"2015","journal-title":"Immunology"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519300254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519300254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:45:23Z","timestamp":1565210723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519300254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":28,"alternative-id":["S0304383519300254"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.01.013","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK\/ERK pathway in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}